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Abstract
Background: Dry socket is one of the most common complications occurring after the e�traction of a permanent 
tooth, but in spite of its high incidence there is not an established treatment for this condition. 
Objectives: Analyze the efficacy of different methods used in the management of dry socket regarding results of 
pain’s relief and alveolar mucosa healing compared to conventional surgical treatment of curettage and saline ir-
rigation. 
Material and Methods: A Cochrane and PubMed-MEDLINE database search was conducted with the search 
terms “dry socket”, “post-extraction complications”, “alvogyl”, “alveolar osteitis” and “fibrynolitic alveolitis”, 
individually and ne�t, using the Boolean operator “AND”. The inclusion criteria were: clinical studies including at 
least 10 patients, articles published from 2004 to 2014 written in English. The e�clusion criteria were case reports 
and nonhuman studies.
Results: 11 publications were selected from a total of 627. Three of the 11 were e�cluded after reading the full 
text. The final review included 8 articles: 3 prospective studies, 2 retrospective studies and 3 clinical trials. They 
were stratified according to their level of scientific evidence using the SORT criteria (Strenght of Recommenda-
tion Ta�onomy).
Conclusions: All treatments included in the review have the aim to relief patient’s pain and promote alveolar mu-
cosa healing in dry socket. Given the heterogeneity of interventions and the type of measurement scale, the results 
are difficult to compare. Curettage and irrigation should be carried out in dry socket, as well as another therapy 
such as LLLT, zinc o�ide eugenol or plasma rich in growth factors, which are the ones that show better results in 
pain remission and alveolar mucosa healing. 
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Assessment alveolar bone esposure must be a factor to consider in future research. Taking into account the scientific 
quality of the articles evaluated, a level B recommendation is given for therapeutic interventions proposed for the 
treatment of dry socket.
Key words: Dry socket, post-extraction complications, alvogyl, alveolar osteitis, fibrynolitic alveolitis.
Introduction
Dry socket, is the most common complication follow-
ing a dental e�traction (1) and one of the most studied 
complications in dentistry (2). There are up to 17 differ-
ent definitions for the clinical diagnosis of dry socket 
(3).  Blum described dry socket as the presence of “post-
operative pain in and around the e�traction site, which 
increases in severity at any time between one and three 
days after the e�traction, accompanied by a partially or 
totally disintegrated blood clot within the alveolar sock-
et, with or without halitosis” (4) e�cluding any other 
cause of pain on the same side of the face (4).
Its incidence is appro�imately 3% for all routine e�trac-
tions and can reach over 30% for impacted mandibular 
third molars (5), and many factors have been cited as 
contributing to the occurrence of dry socket including 
difficult or traumatic extractions, female sex, tobacco 
use, oral contraceptives and pre-e�isting infection (6).
It has been suggested that an increased local fibrinolytic 
activity is the main etiological factor of dry socket. The 
increase in fibrinolytic activity could result in a prema-
ture loss of the intraalveolar blood clot after e�traction 
(7). The fibrinolysis is the result of plasminogen path-
way activation, which can be accomplished via direct 
(physiologic) or indirect (nonphysiologic) activator sub-
stances. Direct activators are released after trauma to 
the alveolar bone cells. Indirect activators are secreted 
by bacteria (8). Apart from the relation with the fibrino-
lytic process the e�act etiology of dry socket is not well 
understood (9,10).
The treatment of alveolitis depends on each profession-
al’s clinical e�perience (11) mainly due to the fact of 
its comple� etiology, although many authors have pub-
lished research on the management of dry socket.
The Cochrane Collaboration published a review on the 
local interventions for the management of dry socket, 
concluding there was no evidence to support any of the 
interventions included for its treatment (12).
The aim of this systematic review is to analyze the dif-
ferent methods used in the management of dry socket 
regarding results of pain’s relief and socket healing and 
the key question to meet the objective was: which medi-
cal treatment over conventional surgical treatment of 
curettage and irrigation with saline gets a faster remis-
sion of the intensity and duration of pain? and secondar-
ily, which treatment promotes alveolar mucosa healing 
more effectively?.
Material and Methods
A Cochrane and PubMed-MEDLINE databases search 
of articles was conducted between October 2013 and 
February 2014. The key words “dry socket”, “post-
e�traction complications”, “alvogyl”, “alveolar osteitis” 
and “fibrynolitic alveolitis” were used.  Next, the terms 
were merged using the Boolean operator “AND”, in or-
der to obtain the articles that included two or more of 
the used search terms.
The inclusion criteria were clinical studies including at 
least 10 patients published from 2004 to 2014 written 
in English. The e�clusion criteria were case reports and 
nonhuman studies.
The articles selection was agreed by consensus between 
two of the authors; first by reading of the titles and ab-
stracts and, in those which seems relevant to identify 
whether they fulfilled the inclusion criteria or not.
Results
Out of the 627 studies obtained initially from the search, 
the complete te�t of 11 articles was analyzed. Three of 
these 11 articles were e�cluded due to the lack of direct 
relationship with the subject and finally, 8 articles with 
relevance were selected to be included in the systematic 
review: 3 prospective studies, 2 retrospective studies 
and 3 clinical trials (Fig. 1).
The articles were stratified according to their level of 
evidence, using the SORT criteria (Strenght of Recom-
mendation Ta�onomy) (13) (Tables 1,2), resulting in 2 
articles with a scientific evidence level of 1 and 6 with a 
scientific evidence level of 2.
The articles included in our review analyze the effec-
tiveness of 8 different methods for the management of 
dry socket, represented in table 3.
Curettage and irrigation are applied to almost all groups 
studied in the articles included in our review (1,14-
16,19), as this seems to be imperative to remove debris, 
sequestra, and bacteria from the denuded bone (20) as a 
unic or as a control treatment or before appliying some 
local therapy.
The studies included in this revision compare the differ-
ent treatments on two variables:
a) Pain’s relief.
As pain is the main symptom of this pathology, nine 
of the selected articles analyze the patient’s pain in 
dry socket and compare different treatments aimed to 
achieve pain remission (1,15,16,19,21-23).
Med Oral Patol Oral Cir Bucal. 2015 Sep 1;20 (5):e633-9.                                                                                                                                                                                    Dry socket management
e635
To assess changes in pain’s intensity, some of the stud-
ies used the Visual Analogue Scale, asking the patients 
to measure their pain ranging from 0 (“no pain at all”) 
to 10 (“the most pain imaginable”), although some stud-
ies considered 8 or 9 the maximum level of pain (14). 
Other methods used to assess pain remission were the 
number of analgesic tablets needed (1), the mg of aceta-
minophen (21) or the percentage of patients who referred 
a pain decrease (16). All these results are quantitatively 
reflected on table 1.
a) Alveolar mucosa healing and alveolar bone e�posi-
tion.
Alveolar mucosa healing is one of the most used signs 
to assess dry socket remission, what is more objectified 
than pain’s relief.
Only three of the studies (14,15,22) including quantita-
tive references of the alveolar mucosa healing evolution 
in those alveoli that had developed dry socket. Socket 
healing was measured with different scales:
- One study observed granulation of the alveoli between 
3 and 5 days of starting treatment in those patients who 
had taken 1 mg 8 hourly 24 hours post-extraction (19).
- Haraji et al. (22) use a gradation to assess alveolar 
post-e�traction complications: 1: clot degeneration, 2: 
wound departure with pus, 3: wound departure without 
pus, 4: no healing.Fig. 1. Flow of articles through the systematic review.
Strenght of 
Recommendation
Definition
A Recommendation based on consistent and good-quality, patient-oriented evidence (1) 
B Recommendation based on inconsistent or limited-quality, patient-oriented evidence (1) 
C
Recommendation based on consensus, usual practice, opinion, disease-oriented evidence 
(2), or on case series for studies of diagnosis, treatment, prevention or screening 
(1) Patient-oriented evidence considers the following objectives: reduction of mortality and morbidity, improvement 
on symptoms, better quality of life, reduced costs.  
(2) Disease-oriented evidence comprises intermediate, histopathologic, physiologic and other surrogate or potentially 
useful results for improving the patient’s quality of life (blood sugar, blood pressure, etc.) that may or not reflect the 
patient’s actual improvement 
Table 1. SORT Criteria (Strength of Recommendation Ta�onomy) (13).
Study quality Diagnosis Treatment/prevention/screening Prognosis 
Level 1: Good-
quality, patient-
oriented evidence 
SR/meta-analysis of high-
quality studies 
High-quality diagnostic 
cohort study 
SR/meta-analysis of RCTs with 
consistent findings  
High quality individual RCT  
All or none studies. 
SR/meta-analysis of good-
quality cohort studies 
Prospective cohort study with 
good follow-up 
Level 2: 
Limited-quality, 
patient-oriented 
evidence 
SR/meta-analysis of low-
quality studies or studies 
with inconsistent findings  
Cohort study or low-
quality case control study 
SR/meta-analysis of low-quality 
clinical trials or of studies with 
inconsistent findings 
Low-quality clinical trial 
Cohort study 
Case control study 
SR/meta-analysis of lower-
quality cohort studies or with 
inconsistent results 
Retrospective cohort study 
with poor follow-up 
Case-control study 
Case series 
Level 3: 
Other evidence 
Consensus guidelines, e�trapolations from bench research, usual practice, opinion, disease-oriented 
evidence, or case series to study diagnosis, treatment, prevention or screening 
Table 2. Levels of scientific evidence SORT (13).
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- Pal et al. (14) punctuate alveolar healing as, 0: no heal-
ing, no clot formation, 0.5: clot formed/seen, 1: clot sta-
bilized, 1.5: ½ of socket epithelialized and covered, 2: 
2/3 of socket epithelialized and covered, 2.5: epitheli-
alization almost complete, wound closed, 3: socket ap-
pears closed with normal mucosa coverage. 
The results of these three studies according to their rat-
ing scale are shown in table 4 and 4 continue.
Alveolar bone e�position (socket empty) is another use-
ful parameter to determine dry socket healing, but it is a 
parameter only included in Kaya et al. study (15). 
Discussion
- Pain Remission
Given the disparity of interventions and the type of 
measurement scale, the results are difficult to compare 
between them.
According to 48 hours values from treatment initia-
tion topical anesthetic gel is more effective than eug-
enol (1). Another method used in pain control is plasma 
rich in growth factors (PRGF) (22), producing a reduc-
tion in pain respect topical anesthesia in the first two 
days, but from the second day the difference between 
the two treatments decreases significantly (P<0.00 for 
each post-e�traction day). As the highest pain inten-
sity in dry socket appears between 48-72 hours post-
e�traction, then  it can be assumed that PRGF is more 
effective in pain control, due because it produces a sig-
nificant pain remission specially from the second day of 
e�traction (22).
There is only one study treating pain with a guaiacol, 
eugenol, chlorobutanol and balsam peru (G.E.C.B.) pas-
tille (21) or vitamin C (16). The first one concludes that 
although traditional treatment with zinc o�ide eugenol 
is acceptable, G.E.C.B. pastille has a faster effect (pain 
remission in 19.87 minutes after G.E.C.B. pastille in-
stead of the 45.53 minutes after zinc o�ide eugenol), 
and the second article concludes that a 4000 mg vita-
min C dose along with curettage and irrigation achieves 
a 100% pain remission in just 4 days, although it has to 
be pointed out that there was no control group to which 
the results were compared.
Kaya et al. (15) conducted a randomized clinical trial 
with the aim to compare the effectiveness of Alvogyl, 
SaliCept and low-level laser therapy (LLLT) in pain 
reduction in dry socket, and concluded that LLLT per-
formed superiorly to SaliCept and alvogyl and achieved 
a pain remission in the third day. The intensity of pain 
decreased more rapidly in all three treatment groups 
than in the control group (P<0.05), treated with curet-
tage and irrigation alone.
Ogunlewe et al. (19) recommend pharmacological treat-
ment in combination with curettage and saline irriga-
tion. In their prospective study a 1 mg acetaminophen 
dose was prescribed 2 hours postoperatively, and then 1 
mg 8 hourly for the next 24 hours. Satisfactory results 
were obtained with this regimen, but the article does not 
show any quantitative references, and the treatment was 
not compared with any other method.
- Alveolar mucosa healing   
Method (o therapeutic intervention?) Features 
Zinc o�ide eugenol (ZOE) (1, 14,21) Gauze or ointment formulation. Antiseptic and anesthetic properties, as it 
depresses sensory receptors involved in pain perception. 
Alvogyl (15) (Septodont, Cambridge, Canada). Includes eugenol as an analgesic, iodoform 
as an antimicrobial and butamen as anesthetic (15). 
G.E.C.B. Pastille (21) (Sultan Company, Kuwait, Kuwait). Includes 3% eugenol, 3% guaiacol and 
1,6% chlorobutanol as effective ingredients, and Balsam Peru as a base. 
Vitamin C (16) Tablet formulation. Wound healing promoter and antio�idant action that 
reduces infection and inflammation.  
SaliCept Patch (17) (Carrington Laboratory, Irving, USA). Contains Acemannan hydrogel, 
obtained from the clear inner gel of Aloe Vera (15), which promotes wound 
healing, augments reticuloendothelial function, regulates the immune 
response and acts as an anti-inflammatory and antibacterial agent. 
Plasma rich in growth factors (PRGF) (14) Contains platelets and fibrinogen, so it promotes wound healing as well as 
osteogenesis. Platelet-derived Growth Factor (PDGF) and Tissular Growth 
Factor (TFG) are some of the Growth Factors in this plasma. 
Topical anesthetic gel Oraqi� (1) (Dentsply Pharmaceutical, York, USA). Contains 2.5% prilocaine, 2.5% 
lidocaine, thermosetting agents, hydrochloric acid and purified water. 
Antiseptic and anesthetic properties.  
Low level laser therapy (LLLT) (15) (Lambda Laser Products, Vicenza, Italy). Antimicrobial potential and 
increases the speed and quality of wound healing. 808 nm, 100-mW 
continuous mode gallium aluminium arsenide diode laser. 
Table 3. Different methods in the management of dry socket.
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Table 4. Results of the articles included in the systematic review (G.E.C.B.: Guaiacol, Eugenol, Chlorobutanol and Balsam Peru mi�ture. 
CHX: Chlorhe�idine. P.R.G.F.: Plasma rich in Growth Factors. (1): (A): = number of analgesic tablets needed, (B) = ibuprofen mg needed, 
(C) =patients % with pain relief. (2): no quantitative reference.
 
Article 
 
Level of 
Scientific 
Evidence 
 
 
Number of 
cases 
 
 
Intervention 
 
Check  
point 
 
Pain results 
 
 
Alveolar 
mucosa 
healing 
results 
 
Alveolar 
bone 
exposition 
results 
Analogue 
Visual Scale 
Pain’s 
relief (1) 
Burgoyne CC et al. 2010 
(1) 
2 35 GROUP 1 
(control)  
Eugenol gauze 
Paracetamol + 
codein 30 mg 
48h 2.69 10.3 (A)   
GROUP 2  
Topical anesthesia 
in gel 
Paracetamol + 
codein 30 mg 
48h 2.49 7.9 (A) 
 
  
Haghighat A et al. 2012 
(21) 
2 30 GROUP 1 
(control) [n=15 ] 
Zinc o�ide 
eugenol + 
ibuprofen  
45.53 
min 
 212 mg 
(B) 
  
GROUP 2 [n= 15] 
GECB pastille + 
ibuprofen 
19.87 
min 
 32 mg 
(B) 
  
Halberstein RA and 
Abrahmsohn GM. 2003 
(16) 
2 24 Curettage and 
irrigation +  
Vitamin C 4.000 
mg / day for 5 
days 
48 hours  
 
58.3% 
(C) 
  
4 days  100% 
(C) 
  
Haraji A et al. 2012 (22) 1 40 patients 
with bilateral 
e�traction 
GROUP 1 [n= 80] 
PRGF gel 
2 days 2.77  3 
days 
2.52  
3 days 2.09  7 
days 
0.66  
4 days 1.69   
GROUP 2 
(control) [n= 80] 
Placebo 
2 days 3.82  3 
days 
4.07  
3 days 3.97  7 
days 
0.95  
4 days 2.19   
Haraji A et al. 2013 (23) 1 80 patients 
(160 alveoli) 
GROUP 1 
[n=160] 
0,2% CHX gel  
   Decrease in 
pain(2) 
 
GROUP 2 
(control) [n= 160] 
Dry gelatin as 
placebo 
     
Kaya GŞ et al. 2011 (15) 2 104 GROUP 1 
(control) [n= 26 ] 
Curettage and 
irrigation 
 
Diagnosis 26  13 empty 
socket 
patients 
13 bone 
e�position 
patients 
3 days 26  5 4 
7 days 23  0 1 
GROUP 1 
(control) [n= 26 ] 
Curettage and 
irrigation 
 
Diagnosis 26  18 9 
3 days 25  4 0 
7 days 3  1 0 
GROUP 3 [n= 26 ] 
Currettage and 
irrigation and 
SaliCept patch 
Diagnosis 26  18 9 
3 days 25  4 0 
7 days 3  1 0 
GROUP 4 [n= 26 ] 
Currettage and 
irrigation and 
laser 
Diagnosis 26  15 13 
3 days 8  0 1 
7 days 1  0 0 
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Results obtained in the studies are hardly comparable 
because of the different measurement scale, but the time 
when alveolar mucosa healing was complete can be as-
sessed in three studies (14,15,22).
According to two of the studies, PRGF in gel formula-
tion produces a faster and better alveolar mucosa heal-
ing, being almost complete 15 days of starting treatment 
(14,22), a little bit earlier than in zinc o�ide eugenol 
group (P<0.01).
Regarding the different therapies compared in the study 
of Kaya et al. (15), none of the patients treated with low-
level laser therapy had empty socket after three days of 
application, so all had begun the healing process, while 
in the group treated with Alvogyl little more than half 
of the patients had started the process (even less than in 
the control group, which was only performed curettage 
and irrigation).
- Alveolar bone e�posure
In Kaya et al. study alveolar bone e�posure decreased 
more rapidly in the SaliCept patch treated group, as in 
three days none of the patients had alveolar bone e�po-
sure. Results of LLLT group were also significant (92% 
patients didn’t have alveolar bone e�position in the 3rd 
day). Curiously, alveolar bone e�posure decrease was 
higher in the control group (69,2%) than in Alvogyl 
treated group (40%) (P > 0.05, standard error 0.117) 
(15).
We can mention finally that there are other publications 
that propose some measures to prevent dry socket, in-
cluding the use of topical antibiotics after third molars 
e�traction (24) or oral antibiotics before dental e�trac-
tion (25). Various items support the preventive effect 
on dry socket of chlorhe�idine. In the meta-analysis by 
Caso et al. (26) they conclude that rinsing with chlo-
rhe�idine on the day of the e�traction and in subsequent 
days may reduce the incidence of dry socket, a result 
corroborated in the study of Hedström and Sjögren 
(27). More recently, Hita-Iglesias et al. (28) have shown 
a greater efficacy of chlorhexidine in gel formulation 
versus rinse on dry socket’s prevention, because of the 
longer chlorhe�idine bioavailability in the applied area 
with gel formulation. 
In regards to the key questions of the article, only 
two articles compare a medical treatment over curet-
tage and irrigation alone as a control (14,15). In both 
articles comparison was made through visual analogue 
scale. Kaya et al. (15) performed alveolar curettage fol-
lowed by through irrigation with a sterile saline solution 
(0.09% NaCl). All debris was removed, taking care to 
avoid dislodging any normal clot found in the socket. 
Curettage and saline irrigation were repeated again 
three days later. The intensity of pain decreased more 
rapidly in all three treatment groups than in the control 
group (P<0.5). This decrease was significantly greater 
for the LLLT group than for the Alvogyl, SaliCept patch 
and control group. Pal et al. (14) permormed only irriga-
tion with saline for the control group of their study with-
out any other manipulation of the socket or any farmac 
and in terms of pain relief, zinc o�ide eugenol dressing 
was more effective than others treatments tested and the 
control group.
In terms of which treatment promotes alveolar mu-
Table 4 Continue. Results of the articles included in the systematic review (G.E.C.B.: Guaiacol, Eugenol, Chlorobutanol and Balsam Peru 
mi�ture. CHX: Chlorhe�idine. P.R.G.F.: Plasma rich in Growth Factors. (1): (A): = number of analgesic tablets needed, (B) = ibuprofen mg 
needed, (C) =patients % with pain relief. (2): no quantitative reference.
 
Ogunlewe MO et al. 
2007 (19) 
 
2 27 patients 
(31 dry socket 
case) 
Paracetamol 1 
mg/8 h for 24 
hours 
3-5 days   Socket 
granulation 
(2) 
 
Pal U S et al. 2013 (14) 
 
2 45 GROUP A [n= 15 ] 
PRGF gelatin 
1 day 1.4  0.9  
2 days 1.8  1.2  
3 days 3.2  1.6  
7 days 6.6  2.2  
15 days 6.6  2.7  
GROUP B [n= 15 ] 
Zinc o�ide 
eugenol 
1 days 5.2  0.2  
2 days 5.7  0.4  
3 days 5.7  0.6  
7 days 5.7  1  
15 days 6.7  2.6  
GROUP C 
(control) [n= 15] 
Sterile saline 
irrigation 
1 day     
2 days     
3 days     
7 days     
15 days     
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cosa healing more effectively, it can be concluded that 
LLLT theraphy and PRGF obtain the fastest healing, ac-
cording to the results of the three articles that assess it 
(14,15,22).
Conclusions 
All treatments included in the review aim to relief pa-
tient’s pain and promote alveolar mucosa healing in 
dry socket. Given the disparity of interventions and the 
type of measurement scale, the results are difficult to 
compare between them. Curettage and irrigation of the 
socket should be carried out in dry socket, as well as 
another therapy such as LLLT, zinc o�ide eugenol or 
plasma rich in growth factors, which are the ones that 
show better results in pain remission and alveolar mu-
cosa healing. 
Assessment of bone e�posure must be a factor to con-
sider in future research and could be complementary to 
alveolar mucosa healing and therefore give a more com-
plete view of the efficacy of the different methods used 
for dry socket treatment.
After the article’s analysis and according to their scien-
tific quality, a level B recommendation is given to all of 
the therapeutic interventions proposed for dry socket’s 
treatment.
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